181 related articles for article (PubMed ID: 31039140)
21. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
22. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
[TBL] [Abstract][Full Text] [Related]
23. Loss of KLF4 and consequential downregulation of Smad7 exacerbate oncogenic TGF-β signaling in and promote progression of hepatocellular carcinoma.
Sun H; Peng Z; Tang H; Xie D; Jia Z; Zhong L; Zhao S; Ma Z; Gao Y; Zeng L; Luo R; Xie K
Oncogene; 2017 May; 36(21):2957-2968. PubMed ID: 28192402
[TBL] [Abstract][Full Text] [Related]
24. The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis.
Yan C; Wang L; Li B; Zhang BB; Zhang B; Wang YH; Li XY; Chen JX; Tang RX; Zheng KY
Parasit Vectors; 2015 Feb; 8():70. PubMed ID: 25649869
[TBL] [Abstract][Full Text] [Related]
25. The Smad family and its role in pancreatic cancer.
Singh P; Wig JD; Srinivasan R
Indian J Cancer; 2011; 48(3):351-60. PubMed ID: 21921337
[TBL] [Abstract][Full Text] [Related]
26. miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway.
Zhu Z; Xu Y; Zhao J; Liu Q; Feng W; Fan J; Wang P
Br J Cancer; 2015 Apr; 112(8):1367-75. PubMed ID: 25867271
[TBL] [Abstract][Full Text] [Related]
27. Loss of Smad7 Promotes Inflammation in Rheumatoid Arthritis.
Zhou G; Sun X; Qin Q; Lv J; Cai Y; Wang M; Mu R; Lan HY; Wang QW
Front Immunol; 2018; 9():2537. PubMed ID: 30450102
[No Abstract] [Full Text] [Related]
28. Wnt-signaling enhances neural crest migration of melanoma cells and induces an invasive phenotype.
Sinnberg T; Levesque MP; Krochmann J; Cheng PF; Ikenberg K; Meraz-Torres F; Niessner H; Garbe C; Busch C
Mol Cancer; 2018 Feb; 17(1):59. PubMed ID: 29454361
[TBL] [Abstract][Full Text] [Related]
29. Inhibitory Smad7: emerging roles in health and disease.
Briones-Orta MA; Tecalco-Cruz AC; Sosa-Garrocho M; Caligaris C; Macías-Silva M
Curr Mol Pharmacol; 2011 Jun; 4(2):141-53. PubMed ID: 21222648
[TBL] [Abstract][Full Text] [Related]
30. SMAD7 is a novel independent predictor of survival in patients with cutaneous melanoma.
Kaczorowski M; Biecek P; Donizy P; Pieniazek M; Matkowski R; Halon A
Transl Res; 2019 Feb; 204():72-81. PubMed ID: 30342000
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory role of Smad7 in hepatocarcinogenesis in mice and in vitro.
Wang J; Zhao J; Chu ES; Mok MT; Go MY; Man K; Heuchel R; Lan HY; Chang Z; Sung JJ; Yu J
J Pathol; 2013 Aug; 230(4):441-52. PubMed ID: 23625826
[TBL] [Abstract][Full Text] [Related]
32. MiR-378 and BMP-Smad can influence the proliferation of sheep myoblast.
Lu Z; Du L; Liu R; Di R; Zhang L; Ma Y; Li Q; Liu E; Chu M; Wei C
Gene; 2018 Oct; 674():143-150. PubMed ID: 29908283
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-like EMT inducer regulates partial phenotype switching in MITF-low melanoma cell lines.
Noguchi K; Dalton AC; Howley BV; McCall BJ; Yoshida A; Diehl JA; Howe PH
PLoS One; 2017; 12(5):e0177830. PubMed ID: 28545079
[TBL] [Abstract][Full Text] [Related]
34. Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney.
Banas MC; Parks WT; Hudkins KL; Banas B; Holdren M; Iyoda M; Wietecha TA; Kowalewska J; Liu G; Alpers CE
J Histochem Cytochem; 2007 Mar; 55(3):275-85. PubMed ID: 17142805
[TBL] [Abstract][Full Text] [Related]
35. Deletion of exon I of SMAD7 in mice results in altered B cell responses.
Li R; Rosendahl A; Brodin G; Cheng AM; Ahgren A; Sundquist C; Kulkarni S; Pawson T; Heldin CH; Heuchel RL
J Immunol; 2006 Jun; 176(11):6777-84. PubMed ID: 16709837
[TBL] [Abstract][Full Text] [Related]
36. C-myc overexpression drives melanoma metastasis by promoting vasculogenic mimicry via c-myc/snail/Bax signaling.
Lin X; Sun R; Zhao X; Zhu D; Zhao X; Gu Q; Dong X; Zhang D; Zhang Y; Li Y; Sun B
J Mol Med (Berl); 2017 Jan; 95(1):53-67. PubMed ID: 27543492
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-365 inhibits growth, invasion and metastasis of malignant melanoma by targeting NRP1 expression.
Bai J; Zhang Z; Li X; Liu H
Int J Clin Exp Pathol; 2015; 8(5):4913-22. PubMed ID: 26191184
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-181c Suppresses the Biological Progression of Osteosarcoma via Targeting SMAD7 and Regulating Transforming Growth Factor-β (TGF-β) Signaling Pathway.
Fu Y; Tang Y; Wang J; Guo Z
Med Sci Monit; 2019 Jun; 25():4801-4810. PubMed ID: 31251735
[TBL] [Abstract][Full Text] [Related]
39. microRNA-7-5p inhibits melanoma cell proliferation and metastasis by suppressing RelA/NF-κB.
Giles KM; Brown RA; Ganda C; Podgorny MJ; Candy PA; Wintle LC; Richardson KL; Kalinowski FC; Stuart LM; Epis MR; Haass NK; Herlyn M; Leedman PJ
Oncotarget; 2016 May; 7(22):31663-80. PubMed ID: 27203220
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas.
Kim YH; Lee HS; Lee HJ; Hur K; Kim WH; Bang YJ; Kim SJ; Lee KU; Choe KJ; Yang HK
Ann Oncol; 2004 Apr; 15(4):574-80. PubMed ID: 15033661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
